Literature DB >> 6249119

Bile duct carcinoma: a late complication of congenital hepatic fibrosis. Case report and review of literature.

J Scott, S Shousha, H C Thomas, S Sherlock.   

Abstract

Bile duct carcinoma is reported in a 50-year old man as a rare late presentation of congenital hepatic fibrosis (CHF). A survey of the world literature suggests that carcinoma occurs with increased frequency in congenital biliary dilatation. It appears to be a particular risk in patients with prolonged survival but is rare in CHF, where portal hypertension and renal insufficiency make the long-term prognosis poor. In this patient the absence of both gastroesophageal varices and renal disease may have permitted longevity with development of carcinoma. The finding of carcinoma arising in the bile ducts distal to the basic lesion of CHF suggests that active carcinogens may be present in the bile in CHF. The tumor in this patient was unusual in producing mucinous biliary obstruction and terminal hypercalcemia.

Entities:  

Mesh:

Year:  1980        PMID: 6249119

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

Review 1.  Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease.

Authors:  Arvind Srinath; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-05       Impact factor: 2.839

Review 2.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 3.  Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.

Authors:  Tarun Rustagi; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2012-06

4.  The risk factors and diagnosis of cholangiocarcinoma.

Authors:  Christopher A Wadsworth; Adrian Lim; Simon D Taylor-Robinson; Shahid A Khan
Journal:  Hepatol Int       Date:  2012-11-10       Impact factor: 6.047

5.  Preoperatively undetected solitary bile duct hamartoma (von Meyenburg complex) associated with esophageal carcinoma.

Authors:  Kenji Mimatsu; Takatsugu Oida; Atsushi Kawasaki; Osamu Aramaki; Youichi Kuboi; Yoshihisa Katsura; Sadao Amano
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

Review 6.  Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.

Authors:  Dalbir S Sandhu; Abdirashid M Shire; Lewis R Roberts
Journal:  Liver Int       Date:  2007-11-21       Impact factor: 5.828

7.  A Glasgow Tipple-transjugular intrahepatic portosystemic shunt insertion prior to Whipple resection.

Authors:  Salman A A Jabbar; Nigel B Jamieson; Andrew J Morris; Karin A Oien; Fraser Duthie; Colin J McKay; Christopher R Carter; Euan J Dickson
Journal:  J Surg Case Rep       Date:  2016-05-13

8.  Demographics, tumor characteristics, treatment, and survival of patients with Klatskin tumors.

Authors:  Prabin Sharma; Siddhartha Yadav
Journal:  Ann Gastroenterol       Date:  2018-02-08

9.  Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention.

Authors:  Chi-Chih Wang; Ming-Hseng Tseng; Sheng-Wen Wu; Tzu-Wei Yang; Hsuan-Yi Chen; Wen-Wei Sung; Chang-Cheng Su; Yao-Tung Wang; Chun-Che Lin; Ming-Chang Tsai
Journal:  World J Gastrointest Oncol       Date:  2020-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.